BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study

Bibliographic Details
Title: BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
Authors: Ezine, Emilien a, b, Da Silva, Angélique c, d, Idoudi, Safa a, Lebbe, Céleste a, b, Chrétien, Basile e, Sassier, Marion c, Alexandre, Joachim f, Dolladille, Charles f, *
Source: In Therapies December 2024
Database: ScienceDirect
More Details
ISSN:00405957
DOI:10.1016/j.therap.2024.12.011
Published in:Therapies
Language:English